Source:http://linkedlifedata.com/resource/pubmed/id/12180836
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2-4
|
pubmed:dateCreated |
2002-8-15
|
pubmed:abstractText |
Heme oxygenase 1 (HO-1) is an enzyme which degrades heme into tree end products: biliverdin, free iron and carbon monoxide. This enzyme has recently been shown to have anti-inflammatory and tissue protective effects. HO-1 expression is involved in organ protection in pathological situations, and immunosuppressive treatments resulting in indefinite graft survival without chronic rejection have been associated with HO-1 expression by cells of the vessel wall. The aim of this study was to analyze the effect of specific HO-1 overexpression. We used a recombinant adenovirus coding for human HO-1 cDNA in a rat aorta chronic rejection model, 30 days after transplantation. Control groups included rats non treated or treated with a non-coding adenovirus Addl324. We first demonstrated that AdHO-1 was efficiently expressed in endothelial cells in vitro, and in rat aortas ex vivo after adenovirus gene transfer. We found that intimal thickening in AdHO-1 treated aortas (10.8 +/- 3.8%, n=5) was significantly decreased compared to untreated (21.2 +/- 5.6%, n = 5) or Addl324-treated (21.1 +/- 1.2%, n = 4) aortas. Immunohistology showed that treatment with AdHO-1 resulted in a significant reduction in leukocyte infiltration and a decreasing number of VSMC in the intima, compared to Addl324-treated aortas. However, this effect of HO-1 on chronic rejection did not imply modifications on numbers of apoptotic cells in the graft or of alloantibody levels. We have demonstrated, for the first time, that specific HO-1 overexpression following gene transfer of HO-1 inhibited chronic rejection by reducing leukocyte and VSMC infiltration of the aorta intima.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0966-3274
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
235-8
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12180836-Adenoviridae,
pubmed-meshheading:12180836-Animals,
pubmed-meshheading:12180836-Aorta,
pubmed-meshheading:12180836-Apoptosis,
pubmed-meshheading:12180836-Arteriosclerosis,
pubmed-meshheading:12180836-Gene Therapy,
pubmed-meshheading:12180836-Gene Transfer Techniques,
pubmed-meshheading:12180836-Graft Rejection,
pubmed-meshheading:12180836-Heme Oxygenase (Decyclizing),
pubmed-meshheading:12180836-Heme Oxygenase-1,
pubmed-meshheading:12180836-Rats,
pubmed-meshheading:12180836-Rats, Inbred Lew
|
pubmed:year |
2002
|
pubmed:articleTitle |
Inhibition of graft arteriosclerosis development in rat aortas following heme oxygenase-1 gene transfer.
|
pubmed:affiliation |
INSERM U437 and ITERT, Nantes, France.
|
pubmed:publicationType |
Journal Article
|